3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, S; Kong, W; Wang, W; Wang, Y | 1 |
| Cheng, X; Dong, L; Hu, Y; Zhou, L | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Chronic Illness
| Article | Year |
|---|---|
Role of P2X7R in eosinophilic and non‑eosinophilic chronic rhinosinusitis with nasal polyps.
Topics: Adenosine Triphosphate; Adult; Aged; Chronic Disease; Eosinophils; Epithelial Cells; Female; Humans; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Middle Aged; Nasal Mucosa; Nasal Polyps; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Receptors, Purinergic P2X7; Rhinitis; Sinusitis; Young Adult | 2021 |
P2X7 receptor antagonist protects retinal ganglion cells by inhibiting microglial activation in a rat chronic ocular hypertension model.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase 1; Chronic Disease; Disease Models, Animal; Gene Expression; Microglia; Ocular Hypertension; Purinergic P2X Receptor Antagonists; Rats; Receptors, Purinergic P2X7; Retina; Retinal Ganglion Cells | 2018 |